2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3651
  



  

  
Submitter : 
  

  
Mrs. Karen Surmont
  

  
Date & Time: 
  

  
12/19/2006 09:12:10
  



  

  
Organization : 
  

  
Mrs. Karen Surmont
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Please issue guidelines to pharmaceutical companies which will restrict their use of stem cell lines from aborted fetuses.  There are non- objectionable cell lines that can be used in the making of vaccines.